| State: | California |
|---|---|
| Address: | 4747 Executive Dr Suite 510, San Diego, CA 92121 |
| Zip code: | 92121 |
| Phone: | (858) 731-8180 |
| Website: | https://ir.odonate.com/contact-ir |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Odonate Therapeutics, Inc., use the form below and your opinion, advice or comment will appear in this space.
The phone number for Odonate Therapeutics, Inc. is (858) 731-8180.
Odonate Therapeutics, Inc. is located at 4747 Executive Dr Suite 510, San Diego, CA 92121
The website (URL) for Odonate Therapeutics, Inc. is: https://ir.odonate.com/contact-ir
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. © 2019 Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent.
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend. Contacts. Odonate Therapeutics, Inc. John Lemkey Chief Operating Officer 858-731-8180 jlemkey@odonate.com.
Odonate Therapeutics, Inc, a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.
Odonate Therapeutics, Inc. careers, pay and expert network. What are the highest paying jobs at Odonate Therapeutics, Inc.? Total value of jobs: $215,000.
Find the latest quotes for (Odonate Therapeutics, Inc. Common Stock) (ODT) as well as charts and news at Nasdaq.com.
Odonate Therapeutics, Inc. (Exact name of registrant as specified in its charter). 4747 Executive Drive, Suite 510. San Diego, CA 92121. (858) 731-8180. (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices).
From BioPortfolio: Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and Printed From BioPortfolio.com. Odonate Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference.